Showing results (191-200 of 272) with videos related to

Sort By:
Pageof 28
Rheumatology (Oxford, England)|November 22, 2022
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysisCorrado Campochiaro, Anna-Maria Hoffmann-Vold, Jerome Avouac, et al.
BMJ Open|June 25, 2021
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trialAnna-Maria Hoffmann-Vold, Håvard H Fretheim, Vikas K Sarna, et al.
BMJ Open Gastroenterology|August 2, 2017
Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohortsElizabeth R Volkmann, Anna-Maria Hoffmann-Vold, Yu-Ling Chang, et al.
Rheumatology (Oxford, England)|October 12, 2022
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by regionAlain Lescoat, Dörte Huscher, Nils Schoof, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2022
Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD TrialEric L Matteson, Clive Kelly, Jörg H W Distler, et al.
BMC Pulmonary Medicine|December 5, 2025
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)Wim A Wuyts, Luca Richeldi, Shervin Assassi, et al.
European Journal of Internal Medicine|August 19, 2025
Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patientsElisabetta Goni, Jens Vikse, Marco Lanzillotta, et al.
RMD Open|February 28, 2025
Validation of a semi-quantitative method to assess interstitial lung disease severity and progression in systemic sclerosis by standard and low-dose HRCT scansLucas Tschalèr, Suzana Jordan, Trond Mogens Aaløkken, et al.
The European Respiratory Journal|October 15, 2021
Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosisJanine Schniering, Malgorzata Maciukiewicz, Hubert S Gabrys, et al.
ERJ Open Research|January 27, 2022
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countriesOle Hilberg, Anna-Maria Hoffmann-Vold, Vanessa Smith, et al.
Pageof 28